{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:54:18Z","timestamp":1789008858651,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01 HL122173"],"award-info":[{"award-number":["P01 HL122173"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41409-021-01498-1","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T21:26:13Z","timestamp":1634419573000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cancers after HLA-matched related bone marrow transplantation for aplastic anemia"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-0244","authenticated-orcid":false,"given":"Phuong","family":"Vo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-7143","authenticated-orcid":false,"given":"Lynn","family":"Onstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-4099","authenticated-orcid":false,"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"key":"1498_CR1","first-page":"44","volume":"1","author":"GW Santos","year":"1969","unstructured":"Santos GW, Owens AH Jr. Allogeneic marrow transplants in cyclophosphamide treated mice. Transplant Proc. 1969;1:44\u201346.","journal-title":"Transplant Proc"},{"key":"1498_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/00007890-196905000-00007","volume":"7","author":"R Storb","year":"1969","unstructured":"Storb R, Epstein RB, Rudolph RH, Thomas ED. Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation. 1969;7:378\u201386.","journal-title":"Transplantation"},{"key":"1498_CR3","first-page":"2195","volume":"30","author":"R Storb","year":"1970","unstructured":"Storb R, Buckner CD, Dillingham LA, Thomas ED. Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Res. 1970;30:2195\u2013203.","journal-title":"Cancer Res"},{"key":"1498_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0140-6736(72)90292-9","volume":"1","author":"ED Thomas","year":"1972","unstructured":"Thomas ED, Buckner CD, Storb R, Neiman PE, Fefer A, Clift RA, et al. Aplastic anaemia treated by marrow transplantation. Lancet. 1972;1:284\u20139.","journal-title":"Lancet"},{"key":"1498_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1182\/blood.V43.2.157.157","volume":"43","author":"R Storb","year":"1974","unstructured":"Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood. 1974;43:157\u201380.","journal-title":"Blood"},{"key":"1498_CR6","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4049\/jimmunol.112.4.1508","volume":"112","author":"R Storb","year":"1974","unstructured":"Storb R, Floersheim GL, Weiden PL, Graham TC, Kolb HJ, Lerner KG, et al. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol. 1974;112:1508\u201316.","journal-title":"J Immunol"},{"key":"1498_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4049\/jimmunol.117.1.143","volume":"117","author":"PL Weiden","year":"1976","unstructured":"Weiden PL, Storb R, Slichter S, Warren RP, Sale GE. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol. 1976;117:143\u201350. e-pub ahead of print 1976\/07\/01","journal-title":"J Immunol"},{"key":"1498_CR8","first-page":"11","volume":"9","author":"D Kotasek","year":"1992","unstructured":"Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant. 1992;9:11\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"1498_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","volume":"84","author":"R Storb","year":"1994","unstructured":"Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 1994;84:941\u20139.","journal-title":"Blood"},{"key":"1498_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1182\/blood.V68.1.119.119","volume":"68","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood. 1986;68:119\u201325.","journal-title":"Blood"},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1182\/blood.V59.2.236.236","volume":"59","author":"R Storb","year":"1982","unstructured":"Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood. 1982;59:236\u201346.","journal-title":"Blood"},{"key":"1498_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al.Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.N Eng J Med.1986;314:729\u201335.","journal-title":"N Eng J Med."},{"key":"1498_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"1498_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.2830110102","volume":"11","author":"KC Doney","year":"1981","unstructured":"Doney KC, Weiden PL, Storb R, Thomas ED. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol. 1981;11:1\u20138.","journal-title":"Am J Hematol"},{"key":"1498_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/00007890-198508000-00011","volume":"40","author":"HJ Deeg","year":"1985","unstructured":"Deeg HJ, Loughran TP Jr., Storb R, Kennedy MS, Sullivan KM, Doney K, et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation. 1985;40:162\u20136. https:\/\/doi.org\/10.1097\/00007890-198508000-00011","journal-title":"Transplantation"},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/0002-9343(85)90221-9","volume":"78","author":"MS Kennedy","year":"1985","unstructured":"Kennedy MS, Deeg HJ, Storb R, Doney K, Sullivan KM, Witherspoon RP, et al. Treatment of acute graft-versus-host disease after allogeneic marrow transplantation: Randomized study comparing corticosteroids and cyclosporine. Am J Med. 1985;78:978\u201383.","journal-title":"Am J Med"},{"key":"1498_CR17","first-page":"791","volume":"18","author":"HJ Deeg","year":"1986","unstructured":"Deeg HJ, Doney K, Sullivan KM, Loughran TP, Appelbaum F, Kennedy M, et al. Antithymocyte globulin followed by cyclosporine for the treatment of acute GVHD in patients given HLA-identical or -nonidentical marrow grafts. Transplant Proc. 1986;18:791\u20133.","journal-title":"Transplant Proc"},{"key":"1498_CR18","first-page":"53","volume":"21","author":"KM Sullivan","year":"1984","unstructured":"Sullivan KM, Deeg HJ, Sanders JE, Shulman HM, Witherspoon RP, Doney K, et al. Late complications after marrow transplantation. Semin Hematol. 1984;21:53\u201363.","journal-title":"Semin Hematol"},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl. 2005;11:945\u201356.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transpl. 2015;21:389\u2013401.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1182\/blood.V72.2.546.546","volume":"72","author":"KM Sullivan","year":"1988","unstructured":"Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood. 1988;72:546\u201354.","journal-title":"Blood"},{"key":"1498_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1182\/blood.V72.2.555.555","volume":"72","author":"KM Sullivan","year":"1988","unstructured":"Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood. 1988;72:555\u201361.","journal-title":"Blood"},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","volume":"125","author":"ME Flowers","year":"2015","unstructured":"Flowers ME, Martin PJ. How we treat chronic graft-versus-host disease. Blood. 2015;125:606\u201315.","journal-title":"Blood"},{"key":"1498_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1182\/blood.V87.1.386.386","volume":"87","author":"HJ Deeg","year":"1996","unstructured":"Deeg HJ, Soci\u00e9 G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386\u201392.","journal-title":"Blood"},{"key":"1498_CR25","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/bmt.2016.198","volume":"51","author":"S Gallo","year":"2016","unstructured":"Gallo S, Woolfrey AE, Burroughs LM, Storer BE, Flowers ME, Hari P, et al. Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GVHD? Bone Marrow Transpl. 2016;51:1573\u20138. https:\/\/doi.org\/10.1038\/bmt.2016.198","journal-title":"Bone Marrow Transpl"},{"key":"1498_CR26","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1056\/NEJM199310143291603","volume":"329","author":"G Soci\u00e9","year":"1993","unstructured":"Soci\u00e9 G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P. et al.Malignant tumors occurring after treatment of aplastic anemia.N Eng J Med. 1993;329:1152\u20137.","journal-title":"N Eng J Med"},{"key":"1498_CR27","unstructured":"ASCO Cancer.Net. Bladder Cancer: Risk Factors. In: American Society of Clinical Oncology (ASCO), 9999."},{"key":"1498_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","volume":"124","author":"C Talar-Williams","year":"1996","unstructured":"Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med. 1996;124:477\u201384. https:\/\/doi.org\/10.7326\/0003-4819-124-5-199603010-00003. e-pub ahead of print 1996\/03\/01","journal-title":"Ann Intern Med"},{"key":"1498_CR29","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3109\/10428194.2012.743657","volume":"54","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang H, Zhou S, Yu M, Wang X, Fu K, et al. Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma. Leuk Lymphoma. 2013;54:1396\u2013404.","journal-title":"Leuk Lymphoma"},{"key":"1498_CR30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMra022137","volume":"348","author":"S Euvrard","year":"2003","unstructured":"Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation (review). N Eng J Med. 2003;348:1681\u201391.","journal-title":"N Eng J Med"},{"key":"1498_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0896-8411(89)80010-1","volume":"2","author":"IT Cockburn","year":"1989","unstructured":"Cockburn IT, Krupp P. The risk of neoplasms in patients treated with cyclosporine A. J Autoimmun. 1989;2:723\u201331. https:\/\/doi.org\/10.1016\/s0896-8411(89)80010-1. e-pub ahead of print 1989\/10\/01","journal-title":"J Autoimmun"},{"key":"1498_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1586\/eci.10.36","volume":"6","author":"M Bewtra","year":"2010","unstructured":"Bewtra M, Lewis JD. Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease. Expert Rev Clin Immunol. 2010;6:621\u201331. https:\/\/doi.org\/10.1586\/eci.10.36. e-pub ahead of print 2010\/07\/03","journal-title":"Expert Rev Clin Immunol"},{"key":"1498_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamadermatol.2015.121","volume":"151","author":"JL DePry","year":"2015","unstructured":"DePry JL, Vyas R, Lazarus HM, Caimi PF, Gerstenblith MR, Bordeaux JS. Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol. 2015;151:775\u201382. https:\/\/doi.org\/10.1001\/jamadermatol.2015.121. e-pub ahead of print 2015\/04\/23","journal-title":"JAMA Dermatol"},{"key":"1498_CR34","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","volume":"105","author":"RE Curtis","year":"2005","unstructured":"Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005;105:3802\u201311. https:\/\/doi.org\/10.1182\/blood-2004-09-3411. e-pub ahead of print 2005\/02\/03","journal-title":"Blood"},{"key":"1498_CR35","first-page":"235","volume":"28","author":"R Storb","year":"1991","unstructured":"Storb R, Anasetti C, Appelbaum F, Bensinger W, Buckner CD, Clift R, et al. Marrow transplantation for severe aplastic anemia and thalassemia major. Semin Hematol. 1991;28:235\u20139.","journal-title":"Semin Hematol"},{"key":"1498_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbmt.2010.10.010","volume":"17","author":"DH Wiseman","year":"2011","unstructured":"Wiseman DH. Donor cell leukemia: a review (review). Biol Blood Marrow Transplant. 2011;17:771\u201389.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1498_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2008.01.036","volume":"132","author":"DJ Rossi","year":"2008","unstructured":"Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer (Review). Cell. 2008;132:681\u201396.","journal-title":"Cell"},{"key":"1498_CR38","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","volume":"141","author":"PC Mayor","year":"2018","unstructured":"Mayor PC, Eng KH, Singel KL, Abrams SI, Odunsi K, Moysich KB, et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United States Immune Deficiency Network Registry. J allergy Clin Immunol. 2018;141:1028\u201335. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.024. e-pub ahead of print 2017\/06\/14","journal-title":"J allergy Clin Immunol"},{"key":"1498_CR39","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood.V51.6.1087.1087","volume":"51","author":"DR Noel","year":"1978","unstructured":"Noel DR, Witherspoon RP, Storb R, Atkinson K, Doney K, Mickelson EM, et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood. 1978;51:1087\u2013105.","journal-title":"Blood"},{"key":"1498_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1182\/blood.V58.2.360.360","volume":"58","author":"RP Witherspoon","year":"1981","unstructured":"Witherspoon RP, Storb R, Ochs HD, Flournoy N, Kopecky KJ, Sullivan KM, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood. 1981;58:360\u20138.","journal-title":"Blood"},{"key":"1498_CR41","doi-asserted-by":"publisher","unstructured":"Williams N, Lee J, Moore L, Baxter JE, Hewinson J, Dawson KJ, et al. Driver mutation acquisition in utero and childhood followed by lifelong clonal evolution underlie myeloproliferative neoplasms (Abstract). Blood. 2020;136:LBA-1-LBA-1. https:\/\/doi.org\/10.1182\/blood-2020-143813","DOI":"10.1182\/blood-2020-143813"},{"key":"1498_CR42","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/bloodadvances.2020002803","volume":"4","author":"I Aldoss","year":"2020","unstructured":"Aldoss I, Song JY, Curtin PT, Forman SJ. Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy. Blood Adv. 2020;4:4798\u2013801. https:\/\/doi.org\/10.1182\/bloodadvances.2020002803. e-pub ahead of print 2020\/10\/07","journal-title":"Blood Adv"},{"key":"1498_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/bmt.2013.127","volume":"49","author":"H Shiozaki","year":"2014","unstructured":"Shiozaki H, Yoshinaga K, Kondo T, Imai Y, Shiseki M, Mori N, et al. Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source. Bone Marrow Transpl. 2014;49:102\u20139. https:\/\/doi.org\/10.1038\/bmt.2013.127. e-pub ahead of print 2013\/09\/10","journal-title":"Bone Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01498-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01498-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01498-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T14:02:36Z","timestamp":1673532156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01498-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01498-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"20 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}